The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...
Главные авторы: | Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
BioMed Central
2007
|
Предметы: |
Схожие документы
-
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
по: Amin, A, и др.
Опубликовано: (2007) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
по: Otieno Dorothy N, и др.
Опубликовано: (2007-05-01) -
The decline in paediatric malaria admissions on the coast of Kenya
по: Okiro, E, и др.
Опубликовано: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
по: Zurovac, D, и др.
Опубликовано: (2007) -
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
по: Wasunna, B, и др.
Опубликовано: (2008)